Gabapentin Capsule
Product Images NDC 85534-0055

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 85534-0055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hawaii Repack, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

Gabapentin-equation (Gabapentin Equation)
This text mentions measurements for age (140 years), weight (in kg), serum creatinine level (in mg/dl), and the correction factor for chloride levels in female patients.*
FDA Label Image

Structure (Gabapentin Fig 5)

FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

Gabapentin-fig1 (Gabapentin Fig1)
This appears to be a chart showing a comparison of mean pain scores between a placebo and a high dose of gabapentin (3600 mg/day) over a 4-week dose titration period followed by a 4-week fixed dose period. The baseline data is also provided for reference.*
FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

Gabapentin-fig2 (Gabapentin Fig2)
This text provides information on a study evaluating mean pain scores at baseline and over several weeks under different dosing regimens, including a placebo, gabapentin at 1800 mg/day, and gabapentin at 2400 mg/day.*
FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

Gabapentin-fig3 (Gabapentin Fig3)
This text provides a graphical representation of the proportion of responders in patients with a 50% reduction in pain score at the endpoint of controlled PHN studies. It shows varying percentages corresponding to different treatment groups such as GBP 3600, PBO, GEBP 1800, and GBP 2400. The statistical significance levels are also indicated for the observed differences in response rates.*
FDA Label Image

Gabapentin-fig4.jpg (Gabapentin Fig4)

FDA Label Image

Image Description (Label 100mg)

FDA Label Image

Image Description (Label 300mg)

FDA Label Image

Image Description (Label 400mg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.